AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ducommun Incorporated

$172.73 +$75.93 (+78.44%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$167.14
Day Range
$166.61$173.07
Year Range
$84.76$210.39
Market Cap
2.61B
AVG Volume
259.23K
Trailing/Forward PE
-95.43/32.21
PEG ratio
-4.26
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0250M500M750M1B2016201720182019202020212022202320242025
DCO Revenue (USD) by year
PeriodRevenue (USD)
2025826.07M
2024786.55M
2023756.99M
2022712.54M
2021645.41M
2020628.94M
2019721.09M
2018629.31M
2017558.18M
2016550.64M
Net Income (USD)
-50M050M100M150M2016201720182019202020212022202320242025
DCO Net Income (USD) by year
PeriodNet Income (USD)
2025-32.06M
202431.5M
202315.93M
202228.79M
2021135.54M
202029.17M
201932.46M
20189.04M
201720.08M
201625.26M
Operating Income (USD)
025M50M75M100M2016201720182019202020212022202320242025
DCO Operating Income (USD) by year
PeriodOperating Income (USD)
202580.12M
202452.21M
202328.92M
202239.79M
202148.88M
202045.51M
201956.23M
201823.92M
201715.03M
201628.57M
EBITDA (USD)
0100M200M300M2016201720182019202020212022202320242025
DCO EBITDA (USD) by year
PeriodEBITDA (USD)
20255.4M
202485.65M
202369.72M
202278.16M
2021210.06M
202074.48M
201984.36M
201855.23M
201738.1M
201652.45M
Cash Flows (USD)
-50M-25M025M50M2016201720182019202020212022202320242025
DCO Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-48.64M
202420.05M
202311.54M
202212.99M
2021-17.43M
2020101K
201932.74M
201828.62M
20177.82M
201626.27M
EPS (USD)
-50510152016201720182019202020212022202320242025
DCO EPS (USD) by year
PeriodEPS (USD)
2025-2.27
20242.1
20231.15
20222.34
202111.07
20202.44
20192.75
20180.78
20171.74
20162.24
Expenses (USD)
050M100M150M200MSG&ACapex2016201720182019202020212022202320242025
DCO Expenses (USD) by year
PeriodExpenses (USD)
2025156.16M
2024152.74M
2023139.25M
2022118.04M
2021110.44M
2020102.32M
2019114.25M
2018101.62M
2017107.05M
201694.63M
Cash & Debt (USD)
0100M200M300M400MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
DCO Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202545.29M
202437.14M
202342.86M
202246.25M
202176.32M
202056.47M
201939.58M
201810.26M
20172.15M
20167.43M
Debt ratios
012320182019202020212022202320242025
DCO Debt ratios by year
PeriodDebt ratios
20251.26
20240.53
20230.58
20220.53
20210.58
20201.11
20191.26
20182.54
Margins
0%10%20%30%2016201720182019202020212022202320242025
DCO Margins by year
PeriodMargins
202526.76%
202425.08%
202321.56%
202220.25%
202122.07%
202021.9%
201921.11%
201819.48%
201718.42%
201619.29%
Return on Capital
-10%0%10%20%30%2016201720182019202020212022202320242025
DCO Return on Capital by year
PeriodReturn on Capital
2025-4.84%
20244.61%
20232.5%
20225.47%
202128.56%
20208.86%
201911.09%
20183.52%
20178.52%
201611.91%
Shares Outstanding
05M10M15M2016201720182019202020212022202320242025
DCO Shares Outstanding by year
PeriodShares Outstanding
202514.94M
202414.82M
202314.64M
202212.12M
202111.92M
202011.72M
201911.57M
201811.41M
201711.25M
201611.18M
Dividends (USD)
00.10.20.32008200920102011
DCO Dividends (USD) by year
PeriodDividends (USD)
20110.07
20100.3
20090.3
20080.15
Employee Count
01K2K3K2016201720182019202020212022202320242025
DCO Employee Count by year
PeriodEmployee Count
20252.13K
20242.18K
20232.27K
20222.46K
20212.48K
20202.45K
20192.8K
20182.6K
20172.6K
20162.7K
Book Value Per Share (USD)
02040602016201720182019202020212022202320242025
DCO Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202544.31
202446.05
202343.46
202243.38
202139.82
202028.1
201925.31
201822.5
201720.95
201618.97
Total Assets (USD)
0500M1B1.5B2016201720182019202020212022202320242025
DCO Total Assets (USD) by year
PeriodTotal Assets (USD)
20251.19B
20241.13B
20231.12B
20221.02B
2021978.74M
2020837.35M
2019790.43M
2018648.14M
2017566.75M
2016515.43M
PE Ratio
2030405060med 37.94Feb 24May 24Sep 24Dec 24Apr 25Jul 25Oct 25
DCO PE Ratio by year
PeriodPE Ratio
Oct 2534.28
Oct 2537.62
Oct 2534.35
Oct 2534.05
Oct 2535.42
Sep 2534.9
Sep 2535.11
Sep 2534.75
Sep 2533.79
Aug 2534.08
Aug 2534.68
Aug 2534.22
Aug 2533.38
Aug 2537.85
Jul 2538.22
Jul 2538.26
Jul 2536.22
Jul 2535.88
Jun 2536.45
Jun 2534.05
Jun 2532.34
Jun 2531.17
May 2529.74
May 2528.62
May 2528.72
May 2527.57
May 2527.76
Apr 2526.87
Apr 2526.63
Apr 2526.14
Apr 2525.53
Mar 2527.51
Mar 2527.68
Mar 2528.22
Mar 2526.62
Feb 2527.58
Feb 2530.41
Feb 2531.04
Feb 2532.94
Jan 2533.94
Jan 2534.5
Jan 2534.02
Jan 2532
Jan 2531.77
Dec 2430.2
Dec 2430.72
Dec 2431.61
Dec 2431.6
Nov 2433.25
Nov 2432.9
Nov 2433.06
Nov 2433.79
Nov 2438.22
Oct 2440.01
Oct 2441.82
Oct 2441.77
Oct 2442.16
Sep 2442
Sep 2442.05
Sep 2441.78
Sep 2439.47
Aug 2442
Aug 2441.89
Aug 2441.45
Aug 2439.82
Aug 2450.63
Jul 2453.76
Jul 2450.57
Jul 2449.95
Jul 2447.92
Jun 2448.62
Jun 2448.59
Jun 2447.57
Jun 2448.56
May 2448.72
May 2448.97
May 2448.66
May 2448.2
May 2451.37
Apr 2449.56
Apr 2447.8
Apr 2450.39
Apr 2444.64
Mar 2447.14
Mar 2446.09
Mar 2446.17
Mar 2445.61
Mar 2444.57
Feb 2444.86
Feb 2438.02
Feb 2438.86
Feb 2438.95
Jan 2439.19
Jan 2438.07
Jan 2438.86
Jan 2439.95
Dec 2340.29
Dec 2340.05
Dec 2339.4
Dec 2340.06
Free Cash Flow Yield
-4%-2%0%2%4%med 2.39%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DCO Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-0.94%
Sep 26-0.96%
Aug 26-0.92%
Aug 26-0.84%
Aug 26-0.78%
Aug 26-0.82%
Jul 26-1.35%
Jul 26-1.36%
Jul 26-1.43%
Jul 26-1.46%
Jul 26-1.29%
Jun 26-1.36%
Jun 26-1.47%
Jun 26-1.47%
Jun 26-1.61%
May 26-1.58%
May 26-1.67%
May 26-1.68%
May 26-2.37%
May 26-2.3%
Apr 26-2.34%
Apr 26-2.36%
Apr 26-2.33%
Apr 26-2.56%
Mar 26-2.7%
Mar 26-2.7%
Mar 26-2.6%
Mar 26-2.53%
Feb 26-2.63%
Feb 262.36%
Feb 262.41%
Feb 262.46%
Jan 262.63%
Jan 262.64%
Jan 262.61%
Jan 262.77%
Jan 263.08%
Dec 253.09%
Dec 253.17%
Dec 253.17%
Dec 253.34%
Nov 253.25%
Nov 253.45%
Nov 253.27%
Nov 253.33%
Oct 252.96%
Oct 252.7%
Oct 252.96%
Oct 252.98%
Oct 252.87%
Sep 252.91%
Sep 252.89%
Sep 252.92%
Sep 253.01%
Aug 252.98%
Aug 252.93%
Aug 252.97%
Aug 253.04%
Aug 251.7%
Jul 251.68%
Jul 251.68%
Jul 251.78%
Jul 251.79%
Jun 251.77%
Jun 251.89%
Jun 251.99%
Jun 252.06%
May 252.16%
May 252.25%
May 252.24%
May 252.33%
May 252.29%
Apr 252.37%
Apr 252.39%
Apr 252.44%
Apr 252.49%
Mar 252.31%
Mar 252.3%
Mar 252.26%
Mar 252.39%
Feb 252.31%
Feb 253.14%
Feb 253.08%
Feb 252.9%
Jan 252.81%
Jan 252.77%
Jan 252.81%
Jan 252.98%
Jan 253.01%
Dec 243.16%
Dec 243.11%
Dec 243.02%
Dec 243.02%
Nov 242.87%
Nov 242.9%
Nov 242.89%
Nov 242.83%
Nov 242.94%
Oct 242.81%
Oct 242.69%
Price to Sales
1234med 1.71Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DCO Price to Sales by year
PeriodPrice to Sales
Sep 263.03
Sep 262.95
Aug 263.09
Aug 263.36
Aug 263.63
Aug 263.46
Jul 263.2
Jul 263.17
Jul 263.01
Jul 262.95
Jul 263.34
Jun 263.18
Jun 262.94
Jun 262.94
Jun 262.68
May 262.72
May 262.58
May 262.57
May 262.48
May 262.55
Apr 262.52
Apr 262.5
Apr 262.53
Apr 262.3
Mar 262.18
Mar 262.18
Mar 262.26
Mar 262.33
Feb 262.24
Feb 262.35
Feb 262.3
Feb 262.25
Jan 262.11
Jan 262.1
Jan 262.12
Jan 262
Jan 261.8
Dec 251.79
Dec 251.75
Dec 251.75
Dec 251.66
Nov 251.7
Nov 251.61
Nov 251.7
Nov 251.66
Oct 251.72
Oct 251.89
Oct 251.73
Oct 251.71
Oct 251.78
Sep 251.75
Sep 251.77
Sep 251.75
Sep 251.7
Aug 251.71
Aug 251.74
Aug 251.72
Aug 251.68
Aug 251.68
Jul 251.7
Jul 251.7
Jul 251.61
Jul 251.6
Jun 251.62
Jun 251.52
Jun 251.44
Jun 251.39
May 251.32
May 251.27
May 251.28
May 251.23
May 251.11
Apr 251.08
Apr 251.07
Apr 251.05
Apr 251.02
Mar 251.1
Mar 251.11
Mar 251.13
Mar 251.07
Feb 251.1
Feb 251.16
Feb 251.18
Feb 251.26
Jan 251.3
Jan 251.32
Jan 251.3
Jan 251.22
Jan 251.21
Dec 241.15
Dec 241.17
Dec 241.21
Dec 241.21
Nov 241.27
Nov 241.26
Nov 241.26
Nov 241.29
Nov 241.13
Oct 241.18
Oct 241.23
EV/EBITDA
0200400600med 15.52Jun 24Sep 24Jan 25Apr 25Aug 25Mar 26Sep 26
DCO EV/EBITDA by year
PeriodEV/EBITDA
Sep 26495.49
Sep 26484.13
Aug 26504.69
Aug 26544.24
Aug 26583.74
Aug 26558.21
May 26435.22
May 26446.31
Apr 26441.25
Apr 26437.34
Apr 26442.85
Apr 26407.03
Mar 26389.71
Mar 26389.13
Mar 26401.8
Mar 26412.2
Feb 26397.49
Oct 2516.76
Oct 2518.17
Oct 2516.79
Oct 2516.66
Oct 2517.24
Sep 2517.02
Sep 2517.11
Sep 2516.96
Sep 2516.55
Aug 2516.68
Aug 2516.93
Aug 2516.74
Aug 2516.38
Aug 2517.48
Jul 2517.62
Jul 2517.64
Jul 2516.84
Jul 2516.71
Jun 2516.93
Jun 2515.99
Jun 2515.32
Jun 2514.87
May 2514.3
May 2513.87
May 2513.91
May 2513.45
May 2512.95
Apr 2512.62
Apr 2512.54
Apr 2512.36
Apr 2512.13
Mar 2512.86
Mar 2512.92
Mar 2513.12
Mar 2512.53
Feb 2512.89
Feb 2513.74
Feb 2513.96
Feb 2514.63
Jan 2514.99
Jan 2515.19
Jan 2515.02
Jan 2514.3
Jan 2514.22
Dec 2413.67
Dec 2413.85
Dec 2414.17
Dec 2414.16
Nov 2414.75
Nov 2414.62
Nov 2414.68
Nov 2414.94
Nov 2414.64
Oct 2415.17
Oct 2415.7
Oct 2415.68
Oct 2415.8
Sep 2415.75
Sep 2415.77
Sep 2415.69
Sep 2415.01
Aug 2415.75
Aug 2415.72
Aug 2415.59
Aug 2415.11
Aug 2415.85
Jul 2416.61
Jul 2415.83
Jul 2415.68
Jul 2415.19
Jun 2415.36
Jun 2415.36
Jun 2415.11
Jun 2415.35
May 2415.39
May 2415.45
May 2415.37
May 2415.26
May 2415.36
Apr 2414.95
Apr 2414.54
Apr 2415.14
Apr 2413.82
Price/Operating Cashflow
152025303540med 24.02May 24Sep 24Dec 24Apr 25Jul 25Nov 25Feb 26
DCO Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Feb 2631.75
Feb 2631.1
Feb 2630.37
Jan 2628.44
Jan 2628.31
Jan 2628.66
Jan 2627.03
Jan 2624.28
Dec 2524.2
Dec 2523.64
Dec 2523.64
Dec 2522.44
Nov 2523
Nov 2521.68
Nov 2522.92
Nov 2522.46
Oct 2524.67
Oct 2527.08
Oct 2524.73
Oct 2524.51
Oct 2525.49
Sep 2525.12
Sep 2525.27
Sep 2525.02
Sep 2524.32
Aug 2524.53
Aug 2524.97
Aug 2524.63
Aug 2524.03
Aug 2536.36
Jul 2536.71
Jul 2536.75
Jul 2534.79
Jul 2534.47
Jun 2535.02
Jun 2532.7
Jun 2531.06
Jun 2529.94
May 2528.57
May 2527.5
May 2527.59
May 2526.48
May 2525.58
Apr 2524.76
Apr 2524.54
Apr 2524.09
Apr 2523.53
Mar 2525.35
Mar 2525.51
Mar 2526
Mar 2524.53
Feb 2525.42
Feb 2521.47
Feb 2521.91
Feb 2523.25
Jan 2523.96
Jan 2524.36
Jan 2524.02
Jan 2522.6
Jan 2522.43
Dec 2421.32
Dec 2421.69
Dec 2422.32
Dec 2422.31
Nov 2423.48
Nov 2423.23
Nov 2423.34
Nov 2423.86
Nov 2420.53
Oct 2421.49
Oct 2422.46
Oct 2422.44
Oct 2422.65
Sep 2422.56
Sep 2422.59
Sep 2422.44
Sep 2421.2
Aug 2422.56
Aug 2422.5
Aug 2422.27
Aug 2421.39
Aug 2418.38
Jul 2419.51
Jul 2418.35
Jul 2418.13
Jul 2417.39
Jun 2417.65
Jun 2417.63
Jun 2417.26
Jun 2417.62
May 2417.68
May 2417.77
May 2417.66
May 2417.49
May 2426.34
Apr 2425.41
Apr 2424.51
Apr 2425.84
Apr 2422.89
Mar 2424.17
Price to Book
12345med 1.96Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DCO Price to Book by year
PeriodPrice to Book
Sep 263.79
Sep 263.69
Aug 263.86
Aug 264.2
Aug 264.54
Aug 264.32
Jul 264.02
Jul 263.99
Jul 263.78
Jul 263.71
Jul 264.19
Jun 263.99
Jun 263.69
Jun 263.7
Jun 263.37
May 263.42
May 263.24
May 263.23
May 263.1
May 263.19
Apr 263.15
Apr 263.11
Apr 263.16
Apr 262.87
Mar 262.73
Mar 262.72
Mar 262.82
Mar 262.91
Feb 262.79
Feb 262.92
Feb 262.86
Feb 262.79
Jan 262.62
Jan 262.6
Jan 262.64
Jan 262.49
Jan 262.23
Dec 252.23
Dec 252.17
Dec 252.17
Dec 252.06
Nov 252.12
Nov 251.99
Nov 252.11
Nov 252.07
Oct 251.94
Oct 252.13
Oct 251.94
Oct 251.92
Oct 252
Sep 251.97
Sep 251.98
Sep 251.96
Sep 251.91
Aug 251.93
Aug 251.96
Aug 251.93
Aug 251.89
Aug 251.92
Jul 251.94
Jul 251.94
Jul 251.84
Jul 251.82
Jun 251.85
Jun 251.73
Jun 251.64
Jun 251.58
May 251.51
May 251.45
May 251.46
May 251.4
May 251.28
Apr 251.24
Apr 251.23
Apr 251.21
Apr 251.18
Mar 251.27
Mar 251.28
Mar 251.3
Mar 251.23
Feb 251.27
Feb 251.36
Feb 251.39
Feb 251.48
Jan 251.52
Jan 251.55
Jan 251.52
Jan 251.43
Jan 251.42
Dec 241.35
Dec 241.38
Dec 241.42
Dec 241.42
Nov 241.49
Nov 241.47
Nov 241.48
Nov 241.51
Nov 241.33
Oct 241.4
Oct 241.46
Ducommun Incorporated
DCO
Stockpicker

Video analysis: DCO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: DCO

TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial

gurufocus.com · 13 Sep 2026

TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial

Updated exploratory results from the ADAURA Phase III trial showed AstraZeneca's TAGRISSOÂ (osimertinib) demonstrated a sustained, clinically meaningful overal

3 Under-the-Radar Defense Stocks With Record Backlogs

marketbeat.com · 7 Sep 2026

3 Under-the-Radar Defense Stocks With Record Backlogs

Life has two constants: death and taxes. But if you were to add a third, it might be the U.S. military expanding its annual budget.

Bank of New York Mellon Corp Invests $8.13 Million in Ducommun Incorporated $DCO

defenseworld.net · 4 Sep 2026

Bank of New York Mellon Corp Invests $8.13 Million in Ducommun Incorporated $DCO

Bank of New York Mellon Corp bought a new stake in shares of Ducommun Incorporated (NYSE: DCO) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,899 shares of the aerospace company's stock, valued at approximately $8,131,000. Bank of New York Mellon

Ducommun to Participate in Gabelli Aerospace & Defense Symposium

globenewswire.com · 3 Sep 2026

Ducommun to Participate in Gabelli Aerospace & Defense Symposium

COSTA MESA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G. Oswald, the Company's chairman, president and chief executive officer, will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026. A general presentation will be held at 11:30 a.m. Eastern, with one-on-one investor meetings scheduled throughout the day.

Ducommun to Participate in B. Riley Consumer & TMT Conference

globenewswire.com · 27 Aug 2026

Ducommun to Participate in B. Riley Consumer & TMT Conference

COSTA MESA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G.

Bank of America Corp DE Increases Holdings in Ducommun Incorporated $DCO

defenseworld.net · 27 Aug 2026

Bank of America Corp DE Increases Holdings in Ducommun Incorporated $DCO

Bank of America Corp DE grew its stake in shares of Ducommun Incorporated (NYSE: DCO) by 18.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 50,637 shares of the aerospace company's stock after buying an additional 7,922 shares during

Ducommun to Participate in Jefferies Industrials Conference

globenewswire.com · 26 Aug 2026

Ducommun to Participate in Jefferies Industrials Conference

COSTA MESA, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G. Oswald, the Company's chairman, president and chief executive officer will participate in the upcoming Jefferies Industrials Conference on September 9, 2026. A general presentation will be held at 11:30 a.m. Eastern, with one-on-one investor meetings scheduled throughout the day.

Buy 3 Mid-Sized Defense Equipment Stocks Amid Geopolitical Conflicts

zacks.com · 25 Aug 2026

Buy 3 Mid-Sized Defense Equipment Stocks Amid Geopolitical Conflicts

AIR, ATRO and DCO stand out as mid-sized defense stocks, backed by rising spending and strong earnings growth.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.